NCT01027481View on ClinicalTrials.gov

Ranibizumab in Patients With Branch Retinal Vein Occlusion

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

December 31, 2009

Conditions
Retinal Vein Occlusion
Interventions
DRUG

Lucentis

intravitreally administration of 0.05 ml Lucentis

Trial Locations (1)

1090

Vienna General Hospital, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT01027481 - Ranibizumab in Patients With Branch Retinal Vein Occlusion | Biotech Hunter | Biotech Hunter